Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Blood

• Publication date

  1993-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V81.3.801.BLOODJOURNAL813801PMID 7679000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells.

  1992cited by this paper
• Autografting in chronic myeloid leukemia with cultured marrow.

  1992cited by this paper
• Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia.

  1992cited by this paper
• Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.

  1992cited by this paper
• Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.

  1992cited by this paper
• Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro.

  1992cited by this paper
• Role of c-kit ligand in the expansion of human hematopoietic progenitor cells.

  1992cited by this paper
• Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells.

  1991cited by this paper
• Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.

  1991cited by this paper
• Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

  1991cited by this paper
• Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.

  1991cited by this paper
• Effect of c-kit ligand on in vitro human megakaryocytopoiesis.

  1991cited by this paper
• Simultaneous use of rhodamine 123, phycoerythrin, Texas red, and allophycocyanin for the isolation of human hematopoietic progenitor cells.

  1991cited by this paper
• Autotransplants in chronic myelogenous leukaemia: strategies and results.

  1990cited by this paper
• Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.

  1990cited by this paper
• Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

  1990cited by this paper
• Detection of the hybrid BCR/ABL messenger RNA in single CFU-GM colonies using the polymerase chain reaction.

  1990cited by this paper
• Marrow repopulating cells, but not CFU-S, establish long-term in vitro hemopoiesis on a marrow-derived stromal layer.

  1990cited by this paper
• Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  1990cited by this paper
• Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help?

  1990cited by this paper
• Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture.

  1989cited by this paper
• Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis

  1989cited by this paper
• Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

  1989cited by this paper
• Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.

  1989cited by this paper
• Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

  1988cited by this paper
• The molecular genetics of Philadelphia chromosome-positive leukemias.

  1988cited by this paper
• Maintenance and proliferation control of primitive hemopoietic progenitors in long-term cultures of human marrow cells.

  1988cited by this paper
• Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Maintenance and proliferation control of primitive hemopoietic progenitors in long-term cultures of human marrow cells.

  1988cited by this paper
• Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.

  1986cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• Cytogenetic studies of early myeloid progenitor compartments in Ph1- positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients

  1984cited by this paper
• Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.

  1984cited by this paper
• Cytogenetic studies of early myeloid progenitor compartments in Ph1‐positive chronic myeloid leukaemia (CML) I. PERSISTENCE OF Ph1‐NEGATIVE COMMITTED PROGENITORS THAT ARE SUPPRESSED FROM DIFFERENTIATING IN VIVO

  1984cited by this paper
• Altered transcription of an oncogene in chronic myeloid leukaemia.

  1984cited by this paper
• Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

  1983cited by this paper
• Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

  1983cited by this paper
• New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment.

  1982cited by this paper
• New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment.

  1982cited by this paper
• Significance of Ph1-negative marrow cells in Ph1-positive chronic granulocytic leukemia.

  1980cited by this paper
• Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.

  1977cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• Clonal origin of chronic myelocytic leukemia in man.

  1967cited by this paper
• A minute chromosome in human chronic granulocytic leukemia

  1960cited by this paper
• Chromosome studies on normal and leukemic human leukocytes.

  1960cited by this paper
• Significance of Ph ’-Negative Marrow Cells in Ph ’-Positive Chronic Granulocytic Leukemia

  year unknowncited by this paper

• Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

  2012cites this paper
• Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells Comparative Analysis of Autografting in Chronic Myelogenous Leukemia

  2010cites this paper
• Strategies to eliminate cancer stem cells: clinical implications.

  2006cites this paper
• Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood

  2005cites this paper
• Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors

  2005cites this paper
• Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.

  2004cites this paper
• Chronic Myelogenous Leukemia

  2004cites this paper
• HLA‐DRB1*16‐restricted recognition of myeloid cells, including CD34+ CML progenitor cells

  2003cites this paper
• The naive T‐lymphocyte compartment is well preserved in patients with chronic myelogenous leukaemia in chronic phase

  2002cites this paper
• myelogenous leukemia progenitors in long-term culture Autologous activated natural killer cells suppress primitive chronic

  2002cites this paper
• Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation

  2001cites this paper
• Immunodeficient mouse models for the quantitative evaluation of normal, genetically marked, and malignant human hematopoietic stem cells

  2001cites this paper
• Persistence of Transcriptionally Silent BCR-ABL Rearrangements in Chronic Myeloid Leukemia Patients in Sustained Complete Cytogenetic Remission

  2001cites this paper
• Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation.

  2000influential citation
• L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.

  2000cites this paper
• Use of Merocyanine 540 for the Isolation of Quiescent, Primitive Human Bone Marrow Hematopoietic Progenitor Cells

  1999cites this paper
• Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia

  1999cites this paper
• BCR/ABL- CD34+HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal

  1999cites this paper
• BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.

  1999cites this paper
• A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct.

  1999cites this paper
• Chronic myeloid leukemia from basics to bedside

  1999cites this paper
• Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.

  1999cites this paper
• Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice

  1999cites this paper
• Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?

  1999cites this paper
• Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.

  1998cites this paper
• Retrovirus and Adenovirus-Mediated Interferon Gene Transfer into Hematopoietic Stem Cells (CD 34+) of Normal and Chronic Myelogenous Leukemia

  1998cites this paper
• Innovative therapy for chronic myelogenous leukemia.

  1998cites this paper
• Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow

  1998influential citation
• Acute Leukemias VII

  1998cites this paper
• Ex vivo cytokine expansion of peripheral blood Ph-negative cells in chronic myeloid leukaemia.

  1998cites this paper
• Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.

  1998cites this paper
• Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?

  1998cites this paper
• Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.

  1998cites this paper
• Gene transfer of alpha interferon into hematopoietic stem cells.

  1998cites this paper
• Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.

  1998cites this paper
• Comparative Analysis of Autografting in Chronic Myelogenous Leukemia: Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells

  1998cites this paper
• Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF

  1998cites this paper
• Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells

  1998cites this paper
• BCR‐ABL‐positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon‐α

  1998cites this paper
• Autologous transplantation for the treatment of chronic myelogenous leukemia.

  1998cites this paper
• Autografting as first line treatment for chronic myeloid leukaemia.

  1998cites this paper
• Autologous transplantation therapy for chronic myelogenous leukemia.

  1997cites this paper
• BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients

  1997cites this paper
• A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.

  1997cites this paper
• Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells

  1997cites this paper
• Stem cells in chronic myelogenous leukemia.

  1997cites this paper
• Gene therapy strategies for leukemia.

  1997cites this paper
• Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia

  1997cites this paper
• Adenovirus Mediated Alpha Interferon (IFN‐α) Gene Transfer into CD34+ Cells and CML Mononuclear Cells

  1997cites this paper
• The 30/35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors

  1997cites this paper
• Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line

  1997cites this paper
• Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia‐negative peripheral blood stem cells

  1997cites this paper
• Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR

  1997cites this paper
• Flow cytometry: recent advances in diagnosis and monitoring of leukemia.

  1997cites this paper
• Ex vivo cytokine expansion of peripheral blood 5‐fluorouracil‐treated CD34‐positive chronic myeloid leukaemia cells increases the selection of Ph‐negative cells

  1997cites this paper
• New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia.

  1997cites this paper
• Retroviral gene therapy in hematopoietic diseases

  1997cites this paper
• Autologous stem cell transplantation for the treatment of chronic myelogenous leukemia.

  1997cites this paper
• Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?

  1997cites this paper
• Chronic myelogenous leukemia: a review.

  1996cites this paper
• Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.

  1996cites this paper
• Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.

  1996cites this paper
• Detection of bcr-abl m-RNA in Single Progenitor Colonies by PCR

  1996cites this paper
• Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123.

  1996cites this paper
• Comparison of different antisense oligonucleotides against the BCR/ABL junction in chronic myelogenous leukemia.

  1996cites this paper
• BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.

  1996cites this paper
• Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.

  1996cites this paper
• The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia

  1996cites this paper
• BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

  1996cites this paper
• Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.

  1996cites this paper
• Defect of stromal microenvironment in long term bone marrow cultures of patients with acute and chronic myelogenous leukemias.

  1995cites this paper
• Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.

  1995cites this paper
• Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells.

  1995cites this paper
• Peripheral blood stem cell transplant: future directions.

  1995cites this paper
• Autografting in chronic myelogenous leukemia: new questions.

  1995cites this paper
• Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.

  1995cites this paper
• Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization.

  1995cites this paper
• Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT).

  1994cites this paper
• Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.

  1994cites this paper
• Long‐term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group

  1994cites this paper
• CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.

  1994cites this paper
• Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine.

  1994cites this paper
• Benign hematopoietic progenitors in chronic myeloid leukemia: Current status and future prospects

  1994cites this paper
• Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment.

  1994cites this paper
• Retroviral mediated gene transfer in chronic myelogenous leukaemia

  1994cites this paper
• Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.

  1994cites this paper
• Identification of Philadelphia-negative granulocyte-macrophage colony- forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients

  1994cites this paper
• [Chronic myeloid leukemia (CML). Molecular biology].

  1993cites this paper
• Therapy of chronic myelogenous leukemia

  1993cites this paper
• Selective overshoot of ph‐negative blood hemopoietic cells after intensive idarubicin‐containing regimen and their repopulating capacity after reinfusion

  1993cites this paper
• Newer approaches in treating chronic myelogenous leukemia

  1993cites this paper
• Characterization and selection of benign stem cells in chronic myeloid leukemia.

  1993cites this paper
• Biological strategies for the selective manipulation of normal and leukemic stem cells

  1993cites this paper
• Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia

  year unknowncites this paper